ADAMTS13 and thrombotic thrombocytopenic purpura: Clinical practice guidelines for the diagnosis and treatment of TTP have highlighted that the measurement of ADAMTS-13 activity and detection of autoantibodies are pivotal in confirming the diagnosis and distinguishing it from other conditions with similar clinical presentations [4].